Subscribe to Newsletter
Business & Regulation Business Practice

Biden’s Legacy; Trump’s Agenda: Part 2

| 7 min read

In part 2 of our roundtable discussion, thought leaders discuss what Trump could do for drug pricing and whether change is to be feared or embraced.

Business & Regulation Trends & Forecasts

Drugs to Watch in 2025: Part 1

| Stephanie Vine | 8 min read

We speak with Clarivate about their report listing eleven key drugs to watch in 2025.

Discovery & Development Drug Delivery

The Force Meets Oligonucleotides

| Stephanie Vine

Researchers develop a new platform to improve delivery of oligonucleotide therapies to muscle.

Discovery & Development Clinical Trials

Asking the Right Questions in R&D

| 3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Business & Regulation Supply Chain

The UK's Radiopharma Revolution

| Juliana Maynard | 6 min read

Radiopharmaceuticals are a promising approach to cancer, but some countries are lagging behind. A collaboration hopes to change that.

Business & Regulation Business Practice

Biden’s Legacy; Trump’s Agenda: Part 1

| 10 min read

Biden pushed drug pricing reforms, whereas Trump is known for deregulation. What does this mean for pharma?

Discovery & Development Drug Discovery

Rethinking Osteoarthritis With Extracellular Vesicles

| 4 min read

Why researchers are excited about the potential of extracellular vesicles from umbilical cord-derived stem cells.

Discovery & Development Drug Discovery

Breaking Through Rare Diseases

| Stephanie Vine | 8 min read

We asked three rare disease drug developers about their work, the challenges facing the field, and what they would do with unlimited funds.

Discovery & Development Drug Delivery

RIDE: A New Approach to CRISPR Delivery

| Rob Coker | 2 min read

A new study reports targeted CRISPR delivery in retinal and neurological disease models – without viral vectors.

Business & Regulation Profession

Sitting Down With... Moncef Slaoui

| 5 min read

The career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register